 | • レポートコード：QYR9NV18481 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、卵巣がんの治療および診断の世界市場について調査・分析し、卵巣がんの治療および診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（手術、放射線療法、薬物治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の卵巣がんの治療および診断市場動向 ・主要企業別マーケットシェア ・卵巣がんの治療および診断の種類別市場規模2014-2019 （手術、放射線療法、薬物治療） ・卵巣がんの治療および診断の用途別市場規模2014-2019 （病院、診療所、その他） ・卵巣がんの治療および診断の北米市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断の中国市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断の日本国内市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断の東南アジア市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断のインド市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Astra Zeneca、Clovis Oncology、Myriad、TESARO、AbbVie Inc、Celgene、Janssen Pharmaceuticals、Merck、Novartis AG、Quest Diagnostics Inc） ・卵巣がんの治療および診断の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and uterine body cancer, some achievements have been made, while the prevention and treatment of ovarian cancer is relatively small.So ovarian cancer is the leading cause of death among cancers of the reproductive system in women.In 2018, the global Therapies and Diagnostics for Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Therapies and Diagnostics for Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Therapies and Diagnostics for Ovarian Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Astra Zeneca
Clovis Oncology
Myriad
TESARO
AbbVie Inc
Celgene
Janssen Pharmaceuticals
Merck
Novartis AG
Quest Diagnostics Inc
Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Drug Treatment
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Therapies and Diagnostics for Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
To present the Therapies and Diagnostics for Ovarian Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Therapies and Diagnostics for Ovarian Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Drug Treatment
1.5 Market by Application
1.5.1 Global Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Therapies and Diagnostics for Ovarian Cancer Market Size
2.2 Therapies and Diagnostics for Ovarian Cancer Growth Trends by Regions
2.2.1 Therapies and Diagnostics for Ovarian Cancer Market Size by Regions (2019-2025)
2.2.2 Therapies and Diagnostics for Ovarian Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Therapies and Diagnostics for Ovarian Cancer Market Size by by Players
3.1.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue by by Players (2014-2019)
3.1.2 Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by by Players (2014-2019)
3.1.3 Global Therapies and Diagnostics for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Therapies and Diagnostics for Ovarian Cancer Key Players Head office and Area Served
3.3 Key Players Therapies and Diagnostics for Ovarian Cancer Product/Solution/Service
3.4 Date of Enter into Therapies and Diagnostics for Ovarian Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2014-2019)
4.2 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2014-2019)
5 North America
5.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
5.2 Therapies and Diagnostics for Ovarian Cancer Key Players in North America
5.3 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type
5.4 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application
6 Europe
6.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
6.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Europe
6.3 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type
6.4 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application
7 China
7.1 China Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
7.2 Therapies and Diagnostics for Ovarian Cancer Key Players in China
7.3 China Therapies and Diagnostics for Ovarian Cancer Market Size by Type
7.4 China Therapies and Diagnostics for Ovarian Cancer Market Size by Application
8 Japan
8.1 Japan Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
8.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Japan
8.3 Japan Therapies and Diagnostics for Ovarian Cancer Market Size by Type
8.4 Japan Therapies and Diagnostics for Ovarian Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
9.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Southeast Asia
9.3 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type
9.4 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application
10 India
10.1 India Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
10.2 Therapies and Diagnostics for Ovarian Cancer Key Players in India
10.3 India Therapies and Diagnostics for Ovarian Cancer Market Size by Type
10.4 India Therapies and Diagnostics for Ovarian Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
11.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Central & South America
11.3 Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size by Type
11.4 Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size by Application
12 International Players Profiles
12.1 Astra Zeneca
12.1.1 Astra Zeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.1.4 Astra Zeneca Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019))
12.1.5 Astra Zeneca Recent Development
12.2 Clovis Oncology
12.2.1 Clovis Oncology Company Details
12.2.2 Company Description and Business Overview
12.2.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.2.4 Clovis Oncology Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.2.5 Clovis Oncology Recent Development
12.3 Myriad
12.3.1 Myriad Company Details
12.3.2 Company Description and Business Overview
12.3.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.3.4 Myriad Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.3.5 Myriad Recent Development
12.4 TESARO
12.4.1 TESARO Company Details
12.4.2 Company Description and Business Overview
12.4.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.4.4 TESARO Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.4.5 TESARO Recent Development
12.5 AbbVie Inc
12.5.1 AbbVie Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.5.4 AbbVie Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.5.5 AbbVie Inc Recent Development
12.6 Celgene
12.6.1 Celgene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.6.4 Celgene Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.6.5 Celgene Recent Development
12.7 Janssen Pharmaceuticals
12.7.1 Janssen Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.7.4 Janssen Pharmaceuticals Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.7.5 Janssen Pharmaceuticals Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.8.4 Merck Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Novartis AG
12.9.1 Novartis AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.9.4 Novartis AG Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.9.5 Novartis AG Recent Development
12.10 Quest Diagnostics Inc
12.10.1 Quest Diagnostics Inc Company Details
12.10.2 Company Description and Business Overview
12.10.3 Therapies and Diagnostics for Ovarian Cancer Introduction
12.10.4 Quest Diagnostics Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
12.10.5 Quest Diagnostics Inc Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Therapies and Diagnostics for Ovarian Cancer Key Market Segments
Table Key Players Therapies and Diagnostics for Ovarian Cancer Covered
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Surgery Figures
Table Key Players of Surgery
Figuer Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figuer Drug Treatment Figures
Table Key Players of Drug Treatment
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Therapies and Diagnostics for Ovarian Cancer Report Years Considered
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Regions 2019-2025 (Million US$)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Regions 2019-2025 (Million US$)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Share by Regions 2014-2019
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Share by Regions 2014-2019
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue by by Players (2014-2019) (Million US$)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Share by by Players (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Share by by Players in 2018
Table Global Therapies and Diagnostics for Ovarian Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Therapies and Diagnostics for Ovarian Cancer Product/Solution/Service
Table Date of Enter into Therapies and Diagnostics for Ovarian Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size Share by Type (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size Market Share by Type (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size Share by Application (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size Market Share by Application (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Application in 2018
Figure North America Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table North America Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table North America Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table North America Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table North America Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Figure Europe Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Figure China Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table China Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table China Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table China Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table China Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Figure Japan Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table Japan Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table Japan Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table Japan Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table Japan Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Figure Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Figure India Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table India Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table India Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table India Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table India Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Figure Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Therapies and Diagnostics for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Therapies and Diagnostics for Ovarian Cancer Market Share (2018-2019)
Table Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size by Type 2014-2019 (Million US$)
Table Central & South America Therapies and Diagnostics for Ovarian Cancer Market Share by Type 2014-2019
Table Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size by Application 2014-2019 (Million US$)
Table Central & South America Therapies and Diagnostics for Ovarian Cancer Market Share by Application 2014-2019
Table Astra Zeneca Company Details
Table Astra Zeneca Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Astra Zeneca Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Astra Zeneca Recent Development
Table Clovis Oncology Company Details
Table Clovis Oncology Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Clovis Oncology Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Clovis Oncology Recent Development
Table Myriad Company Details
Table Myriad Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Myriad Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Myriad Recent Development
Table TESARO Company Details
Table TESARO Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure TESARO Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table TESARO Recent Development
Table AbbVie Inc Company Details
Table AbbVie Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure AbbVie Inc Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table AbbVie Inc Recent Development
Table Celgene Company Details
Table Celgene Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Celgene Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Celgene Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Merck Company Details
Table Merck Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Merck Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Novartis AG Recent Development
Table Quest Diagnostics Inc Company Details
Table Quest Diagnostics Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business 2014-2019 (Million US$)
Figure Quest Diagnostics Inc Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
Table Quest Diagnostics Inc Recent Development
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size Share by Regions (2019-2025)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size Share by Regions in 2025
Figure North America Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size by Product (2019-2025)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size by Product in 2025
Table Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2025)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
卵巣がんの治療および診断のグローバル市場：規模・現状・予測2019-2025 Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and …- 世界及び中国の表皮性卵巣がん治療薬市場2018 The 'Global and Chinese Epithelial Ovarian Cancer Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Epithelial Ovarian Cancer Drug industry with a focus on the Chinese market. The report provides key statistics on the market stat…
- 乳がん診断および薬物技術のグローバル市場：規模・現状・予測2019-2025 Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to rea…
- 乳がん診断および薬物技術のグローバル市場：規模・現状・予測2019-2025 Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to rea…
- 頭頸部癌診断の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary g…